Login
Home / 2186.HK : HKSE
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Luye Pharma Group Ltd.

HKD 1.79 -$0.98 (-35.38%)
HKSE · 14 Sep 2026 08:08 UTC
Previous Close
HKD 1.8
Day Range
HKD 1.77HKD 1.83
Year Range
HKD 1.73HKD 3.83
Market Cap
7.15B
AVG Volume
39.74M
Trailing/Forward PE
8.88/9.54
PEG ratio
4.39
Dividend Yield
-
Next Earnings Date
2027-03-31
Primary Exchange
Hong Kong Stock ExchangeHK
Revenue (CNY)
01B2B3B4B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Net Income (CNY)
-750M-500M-250M0250M500M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Operating Income (CNY)
-250M0250M500M750M1B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
EBITDA (CNY)
0500M1B1.5B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Cash Flows (CNY)
-1B01B2B21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
EPS (CNY)
-0.2-0.100.121 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Expenses (CNY)
-1B01B2B3BR&DSG&ACapex21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Cash & Debt (CNY)
05B10B15BCashLong Term DebtShort Term Debt21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Debt ratios
-0.500.511.5221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Margins
0%20%40%60%80%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Return on Capital
-7.5%-5%-2.5%0%2.5%5%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Shares Outstanding
02B4B6B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Dividends (CNY)
00.020.040.060.08Oct 16Jun 17Oct 17Jun 18Sep 18Jun 19Sep 19Jun 20
Book Value Per Share (CNY)
024621 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Total Assets (CNY)
010B20B30B40B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
PE Ratio
468101214med 7.6Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Free Cash Flow Yield
-10%0%10%20%med 3.56%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
0.40.60.811.2med 0.72Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
123456med 3.9Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price/Operating Cashflow
2468med 3.69Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Book
0.20.40.60.81med 0.56Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Luye Pharma Group Ltd.
2186.HK
Stockpicker

Video analysis: 2186.HK

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.